Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer
Details
Publication Year 2023-03,Volume 30,Issue #3,Page 1614-1625
Journal Title
Annals of Surgical Oncology
Publication Type
Research article
Abstract
BACKGROUND: In esophageal cancer (EC), there is a paucity of knowledge regarding the interplay between the tumor immune microenvironment and response to neoadjuvant treatment and, therefore, which factors may influence outcomes. Thus, our goal was to investigate the changes in the immune microenvironment with neoadjuvant treatment in EC by assessing the expression of immune related genes and their association with prognosis. METHODS: We examined the transcriptome of paired pre- and post-neoadjuvant treated EC specimens. Based on these findings, we validated the presence of tumor-infiltrating neutrophils using CD15(+) immunohistochemistry in a discovery cohort of patients with residual pathologic disease. We developed a nomogram as a predictor of progression-free survival (PFS) incorporating the variables CD15(+) cell count, tumor regression grade, and tumor grade. RESULTS: After neoadjuvant treatment, there was an increase in genes related to myeloid cell differentiation and a poor prognosis associated with high neutrophil (CD15(+)) counts. Our nomogram incorporating CD15(+) cell count was predictive of PFS with a C-index of 0.80 (95% confidence interval [CI] 0.68-0.9) and a concordance probability estimate (CPE) of 0.77 (95% CI 0.69-0.86), which indicates high prognostic ability. The C-index and CPE of the validation cohort were 0.81 (95% CI 0.69-0.91) and 0.78 (95% CI 0.7-0.86), respectively. CONCLUSIONS: Our nomogram incorporating CD15(+) cell count can potentially be used to identify patients at high risk of recurrent disease and thus stratify patients who will benefit most from adjuvant treatment.
Publisher
Springer Nature
Keywords
Humans; *Neutrophils/pathology; Neoadjuvant Therapy; *Esophageal Neoplasms/pathology; Prognosis; Nomograms; Tumor Microenvironment
Department(s)
Laboratory Research; Surgical Oncology; Pathology
PubMed ID
36183015
Open Access at Publisher's Site
https://doi.org/10.1245/s10434-022-12562-5
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-06-22 07:56:51
Last Modified: 2023-06-22 07:57:28

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙